Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|
Total Revenue | 2,231 | 2,523 | 0 | -- |
Cost of Revenue | -- | -- | -- | -- |
Gross Profit | 2,231 | 2,523 | -- | -- |
Operating Expenses | ||||
Research Development | 7,587 | 19,836 | -- | -- |
Selling General and Administrative | 5,374 | 6,910 | -- | -- |
Non Recurring | -- | -- | -- | -- |
Others | (13) | 0 | 1,369 | -- |
Total Operating Expenses | 12,949 | 26,745 | 1,369 | -- |
Operating Income or Loss | (10,718) | (24,222) | (1,369) | -- |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (446) | (124) | 3,298 | -- |
Earnings Before Interest And Taxes | (10,285) | (25,011) | (1,369) | -- |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | (10,639) | (25,121) | 2,649 | -- |
Income Tax Expense | (77) | (175) | 244 | -- |
Minority Interest | (328) | (315) | -- | -- |
Net Income From Continuing Ops | (10,626) | (25,085) | 2,405 | -- |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | -- |
Net Income | (10,626) | (25,085) | 2,405 | -- |
Preferred Stock And Other Adjustments | -- | -- | -- | -- |
Net Income Applicable To Common Shares | (10,626) | (25,085) | 2,403 | -- |